Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models ; volume:69 ; number:1 ; day:5 ; month:12 ; year:2019 ; pages:135-145 ; date:1.2020
Cancer immunology immunotherapy ; 69, Heft 1 (5.12.2019), 135-145, 1.2020
- Urheber
-
Zhang, Rui
Yuan, Fengjiao
Shu, Yang
Tian, Yaomei
Zhou, Bailing
Yi, Linglu
Zhang, Xueyan
Ding, Zhenyu
Xu, Heng
Yang, Li
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-019-02448-z
- URN
-
urn:nbn:de:101:1-2020041406505151541544
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Rui
- Yuan, Fengjiao
- Shu, Yang
- Tian, Yaomei
- Zhou, Bailing
- Yi, Linglu
- Zhang, Xueyan
- Ding, Zhenyu
- Xu, Heng
- Yang, Li
- SpringerLink (Online service)
Ähnliche Objekte (12)
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
Neoantigen‐based vaccines as a promising strategy in cancer immunotherapeutics
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Personalized neoantigen cancer vaccines: current progression, challenges and a bright future
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Development of therapeutic vaccines for the treatment of diseases
Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines
Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model
Evaluation of the antitumor effect of neoantigen peptide vaccines derived from the translatome of lung cancer
Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
Neoantigen‐based vaccines as a promising strategy in cancer immunotherapeutics
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Personalized neoantigen cancer vaccines: current progression, challenges and a bright future
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Development of therapeutic vaccines for the treatment of diseases
Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines
Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model
Evaluation of the antitumor effect of neoantigen peptide vaccines derived from the translatome of lung cancer
Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
Neoantigen‐based vaccines as a promising strategy in cancer immunotherapeutics
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Personalized neoantigen cancer vaccines: current progression, challenges and a bright future
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Development of therapeutic vaccines for the treatment of diseases
Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines
Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model
Evaluation of the antitumor effect of neoantigen peptide vaccines derived from the translatome of lung cancer